Travere Therapeutics, Inc.TVTXNASDAQ
Loading
Cash Generation ExpandingExpanding
Percentile Rank100
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$37.78M
↑ 147% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthExpanding
Average
$-80.09M
Historical baseline
PeriodValueYoY Change
2025$37.78M+115.9%
2024$-237.47M+15.2%
2023$-280.02M-50.3%
2022$-186.29M-1159.4%
2021$-14.79M+65.4%
2020$-42.74M+26.6%
2019$-58.21M-133.2%
2018$-24.96M-437.1%
2017$7.40M+563.8%
2016$-1.60M-